Table of Contents

Foreword. Acknowledgments. Allied Capital Stock Price Chart. Who's Who. Introduction: The Spark of a Speech. Part One: A Charity Case and Greenlight Capital. Chapter 1 Before Greenlight. Chapter 2 Getting the "Greenlight". Chapter 3 Greenlight's Early Success. Chapter 4 Value Investing through the Internet Bubble. Chapter 5 Dissecting Allied Capital. Part Two: Spinning So Fast Leaves Most People Dizzy. Chapter 6 Allied Talks Back. Chapter 7 Wall Street Analysts. Chapter 8 The You-Have-Got-to-Be-Kidding-Me Method of Accounting. Chapter 9 Fact?Or Maybe Not. Chapter 10 Business Loan Express. Chapter 11 Disengaging and Re-engaging. Chapter 12 Me or Your Lyin' Eyes? Chapter 13 Debates and Manipulations. Chapter 14 Rewarding Shareholders. Chapter 15 BLX Is Worth What, Exactly? Part Three: Would Somebody, Anybody, Wake Up? Chapter 16 The Government Investigates. Chapter 17 A Tough Morning. Chapter 18 A Spinner, a Scribe, and a Scholar. Chapter 19 Kroll Digs Deeper. Chapter 20 Rousing the Authorities. Chapter 21 A $9 Million Game of Three-Card Monte. Part Four: How the System Works (and Doesn?t). Chapter 22 Hello, Who's There? Chapter 23 Whistle-Blower. Chapter 24 A Naked Attack. Chapter 25 Another Loan Program, Another Fraud. Chapter 26 The Smell of Politics. Chapter 27 Insiders Getting the Money Out. Part Five: Greenlight Was Right . . . Carry On. Chapter 28 Charges and Denials. Chapter 29 Charges and Admissions. Chapter 30 Late Innings. Chapter 31 The SEC Finds a Spot under the Rug. Chapter 32 A Garden of Weeds. Chapter 33 A Conviction, a Hearing, and a Dismissal. Chapter 34 Blind Men, Elephants, Moebius Strips, and Moral Hazards. Glossary. About the Author. Index.

About the Author

DAVID EINHORN is the president of Greenlight Capital, which he cofounded in January 1996. Greenlight Capital is a value-oriented investment advisor whose goal is to achieve high absolute rates of return while minimizing the risk of capital loss. Einhorn is the Chairman of Board of Greenlight Capital RE and also serves on the boards of Hillel; The Michael J. Fox Foundation for Parkinson's Research; and of the Robin Hood Foundation.